PRELUDE CAPITAL MANAGEMENT, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$50,000
+2400.0%
29,598
+1245.4%
0.00%
Q3 2020$2,000
+100.0%
2,2000.0%0.00%
Q2 2020$1,000
-90.0%
2,200
+82.9%
0.00%
-100.0%
Q2 2014$10,0001,2030.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Cypress Capital Management LLC (WY) 234,225$132,0000.18%
Noven Financial Group, Inc. 123,772$70,0000.04%
Harvest Investment Services, LLC 109,443$60,0000.04%
GSA CAPITAL PARTNERS LLP 559,489$314,0000.03%
COURIER CAPITAL LLC 354,973$199,0000.03%
Valeo Financial Advisors, LLC 330,000$185,0000.02%
Transform Wealth, LLC 205,481$115,0000.02%
WEDBUSH SECURITIES INC 326,793$184,0000.02%
STEEL GROVE CAPITAL ADVISORS, LLC 55,500$31,0000.02%
MONTAG A & ASSOCIATES INC 230,000$129,0000.01%
View complete list of AMPIO PHARMACEUTICALS INC shareholders